looks like mission accomplished. destroy the share price with...

looks like mission accomplished. destroy the share price with shorting and lending out their holdings to ensure company is always maximising dilution when raising capital allowing them to pick up more than their fair share of the discounted shares. never costs them anything as they make so much from shorting the company. when you own this many shares, you do as you please with the company's SP.

keeping the SP low and pissing on the company to let everyone knows it owns it, also ensures no other fund touches the company. the low SP also guarantees the company can never raise enough in one go to fund its trials.

megan and co directors make mesoblast's financial management look genius. at least they have an excuse of failed trials and approvals. all these guys had to do was the simple task of raising enough money to fund their trials, promote the company until that goal was achieved. phase 2b results was a no brainer to fund to any respectable biotech fund.